APA (7th ed.) Citation

Zhicheng Deng, Zhicheng Deng, Guanghui Chen, Yonghui Shi, Ying Lin, Jiebin Ou, . . . Li Lv. (2022). Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Zhicheng Deng, et al. Curcumin and Its Nano-formulations: Defining Triple-negative Breast Cancer Targets Through Network Pharmacology, Molecular Docking, and Experimental Verification. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Zhicheng Deng, et al. Curcumin and Its Nano-formulations: Defining Triple-negative Breast Cancer Targets Through Network Pharmacology, Molecular Docking, and Experimental Verification. Frontiers Media S.A., 2022.

Warning: These citations may not always be 100% accurate.